Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
Price Target
Average
66.43%
Revenue Forecast
Estimate
7.87%
EBIT
Estimate
18.80%
Net Income
Estimate
14.60%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Regeneron Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for REGN of $1.15 K, with forecasts ranging from
a
low of
$805 to a high of $1.3 K.
REGN Lowest Price Target
Wall Street Target
805 USD
16.52%
REGN Average Price Target
Wall Street Target
1.15 K USD
66.43%
REGN Highest Price Target
Wall Street Target
1.3 K USD
88.16%
REVENUE FORECAST
Revenue Forecast Chart REGN
EBIT FORECAST
EBIT Forecast Chart REGN
NET INCOME FORECAST
Net Income Chart REGN